These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1621012)

  • 41. Thyrotropin-releasing hormone in acute pancreatitis. A preliminary report.
    Kiviniemi H; Laitinen S; Ståhlberg M; Larmi M; Kairaluoma M
    Acta Chir Scand; 1986 Jan; 152():43-7. PubMed ID: 2420106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bedside and electro-oculographic analysis of abnormal ocular movements in spinocerebellar degenerations: effects of thyrotropin-releasing hormone.
    Yamamoto H; Saito S; Sobue I
    Neurology; 1988 Jan; 38(1):110-4. PubMed ID: 3122069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of thyrotropin-releasing hormone (TRH) on status epilepticus in rats].
    Osonoe K; Mori N; Ohno E; Kumashiro H
    No To Shinkei; 1991 Mar; 43(3):247-54. PubMed ID: 1907468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of endogenous depressions with thyrotropin-releasing hormone (TRH) under oral administration.
    Schmidt J
    Acta Psychiatr Scand; 1977 Feb; 55(2):142-6. PubMed ID: 402795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
    Ijiro T; Yaguchi A; Yokoyama A; Abe Y; Kiguchi S
    Eur J Pharmacol; 2020 Sep; 882():173271. PubMed ID: 32534077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired Feedforward Control and Enhanced Feedback Control of Speech in Patients with Cerebellar Degeneration.
    Parrell B; Agnew Z; Nagarajan S; Houde J; Ivry RB
    J Neurosci; 2017 Sep; 37(38):9249-9258. PubMed ID: 28842410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of thyrotropin-releasing hormone (TRH) on motor performance of hemiparetic stroke patients.
    Nakamura R; Fujita M
    Tohoku J Exp Med; 1990 Feb; 160(2):141-3. PubMed ID: 2112792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.
    Callahan AM; Frye MA; Marangell LB; George MS; Ketter TA; L'Herrou T; Post RM
    Biol Psychiatry; 1997 Feb; 41(3):264-72. PubMed ID: 9024949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of Thyrotropin-Releasing Hormone Analog for Protracted Disturbance of Consciousness due to Aneurysmal Subarachnoid Hemorrhage.
    Shibata A; Matano F; Fujiki Y; Mizunari T; Murai Y; Yokota H; Morita A
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):988-993. PubMed ID: 30660483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical studies of thyrotropin-releasing hormone tartrate (TRH-T) as a direct stimulant to the central nervous system.
    Ogashiwa M; Takeuchi K
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):145-51. PubMed ID: 36357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D
    J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET study in a patient with spinocerebellar degeneration before and after long-term administration of thyrotropin releasing hormone.
    Tanji H; Nagasawa H; Hayashi T; Onodera H; Fujiwara T; Itoh M; Ido T; Itoyama Y
    Behav Neurol; 1996; 9(3):171-5. PubMed ID: 24487517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and CNS effects of oral and I.V. Thyrotropin-releasing hormone in depressed patients.
    Itil TM; Patterson CD; Polvan N; Bigelow A; Bergey B
    Dis Nerv Syst; 1975 Sep; 36(9):529-36. PubMed ID: 809253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement in ratings of tension after TRH administration in healthy women.
    Winokur A; Amsterdam JD; Mihailovic V; Caroff SN
    Psychoneuroendocrinology; 1982; 7(2-3):239-44. PubMed ID: 6817361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropathology of late cortical cerebellar atrophy in Japan: distribution of cerebellar change on an autopsy case and review of Japanese cases.
    Tsuchiya K; Ozawa E; Saito F; Irie H; Mizutani T
    Eur Neurol; 1994; 34(5):253-62. PubMed ID: 7995299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacotherapy of voice and articulation disorders in aphasia].
    Hacki T; Kenklies M; Hofmann R; Haferkamp G
    Folia Phoniatr (Basel); 1990; 42(6):283-8. PubMed ID: 1707026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Observations on the clinical assessment of patients with motor neuron disease. Experience with a TRH analogue.
    Guiloff RJ; Eckland DJ
    Neurol Clin; 1987 Feb; 5(1):171-92. PubMed ID: 3104752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [TRH stimulation test in hereditary ataxia].
    Lufei HQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Jun; 20(3):154-6. PubMed ID: 3115733
    [No Abstract]   [Full Text] [Related]  

  • 60. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.